p16INK4a and DNA methylation clocks in women treated with chemotherapy for early breast cancer

By afschroeder • September 11, 2026

Muss HB, Sun C, Ding YC, Ji J, White TA, Nyrop K, LeBrasseur NK, Neuhausen SL, Mitin N, Sedrak MS. p16^INK4a and DNA methylation clocks in women treated with chemotherapy for early breast cancer. Geroscience. 2026 Sep 10. doi: 10.1007/s11357-026-02521-3. Epub ahead of print. PMID: 42720847.

Tags: Biomarkers of aging, breast cancer, Cellular senescence, chemotherapy, DNA methylation, epigenetic clocks, Hematology/Oncology, P16INK4a, Publications

Pembrolizumab plus gemcitabine and cisplatin for advanced biliary tract cancer: longer-term follow-up from the randomised, double-blind, placebo-controlled, phase 3 KEYNOTE-966 trial

Ueno M, Yoo C, Ren Z, Furuse J, Kelley RK, Chan SL, Edeline J, Klümpen HJ, Yau T, Verslype C, Ozaka M, Bouattour M, Park[...]

Brief Report: Combination Capmatinib and Trametinib in Metastatic MET-Driven NSCLC

Brown T, Lara MS, Jiang F, Garon EB, Goldman JW, Riess JW, Blakely CM. Brief Report: Combination Capmatinib and Trametinib in Metastatic MET-Driven NSCLC. JTO[...]

Susan Ettner, PhD and Dennis J. Slamon, MD, PhD Elected to the National Academy of Medicine

The UCLA Department of Medicine (DoM) is pleased to congratulate Susan Ettner, PhD and Dennis Slamon, MD, PhD, on their election to the National Academy[...]